K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENTSupporting their immune system healthHill’s Prescription Diet i/d is formulated with clinically proven antioxidants to support healthy immune systems for cats. + Learn More